Introduction

Fenzian is now attracting increasing interest amongst medical professionals following a twelve year development process by the Fenzian team under Mr James Colthurst FRCS(Edin), a UK surgeon. This seemingly long development story has taken Fenzian through several prototypes as well the hoops of regulatory requirements both in the EU (CE) and the US where it is registered under the US FDA 510(k) process. Just as the safety of the equipment had to be ensured, so the efficacy needed validation.

A 600 patient audit, published in the Pain Clinic in 2007, was used to guide the choice of investment in clinical studies.

As a formal medical treatment system, Fenzian has been carefully designed to be suitable for medically qualified practitioners, such as doctors, nurses and physiotherapists. The importance of a sound medical knowledge-base has been shown to be highly valuable in ensuring good Fenzian treatment results.

The relative ease of including Fenzian within existing practice environments renders it suitable in all medical organisations from highly complex modern hospital settings, isolated medical practices as well as individual practitioners – the broad capability covered by a relatively small, easily portable device should also prove to be extremely valuable for medical personnel operating in remote environments.